Suggested Use:

For adults, take 4 capsules daily, preferably with a meal, or as directed by a physician. For those with a sensitive constitution, take 2 capsules twice daily.

Caution: 

Do not exceed recommended dose. Pregnant and nursing mothers, children under the age of 18, and individuals with a known medical condition or taking prescription medication should consult a physician before taking this or any dietary supplement.

[1] Office of Population Affairs. (2019, February 21). Female infertility. https://www.hhs.gov/opa/reproductive-health/fact-sheets/female-infertility/index.html 

[2] Cleveland Clinic. (2016, May 10). Infertility causes. https://my.clevelandclinic.org/health/diseases/16083-infertility-causes 

[3] Lisi, F., Carfagna, P., Oliva, M. M., Rago, R., Lisi, R., Poverini, R., Manna, C., Vaquero, E., Caserta, D., Raparelli, V., Marci, R., & Moscarini, M. (2012). Pretreatment with myo-inositol in non polycystic ovary syndrome patients undergoing multiple follicular stimulation for IVF: a pilot study. Reproductive Biology and Endocrinology, 10(52), 1-7. http://www.rbej.com/content/10/1/52 

[4] Kalra, B., Kalra, S., & Sharma, J. (2016). The inositols and polycystic ovary syndrome. Indian Journal of Ednocrinology and Metabolism, 20(5), 720-724. DOI: 10.4103/2230-8210.189231

[5] Benelli, E., Del Ghianda, S., Di Cosmo, C., & Tonacchera, M. (2016). A combined therapy with myo-inositol and d-chiro-inositol improves endocrine parameters and insulin resistance in PCOS young overweight women. International Journal of Endocrinology. DOI: http://dx.doi.org/10.1155/2016/3204083

[6] Sortino, M. A., Salomone, S., Carruba, M. O., & Drago, F. (2017). Polycystic ovary syndrome: insights into the therapeutic approach with inositols. Journal Frontiers in Pharmacology, 8(341), 1-13. DOI: 10.3389/fphar.2017.00341

[7] Papaleo, E., Unfer, V., Baillargeon, J.P., & Chiu, T.T. (2009). Contribution of myo-inositol to reproduction. European Journal of Obstetrics & Gynecology and Reproductive Biology, 147(2), 120-123. DOI: https://doi.org/10.1016/j.ejogrb.2009.09.008

[8] Carlomagno, G., Unfer, V., & Roseff, S. (2011). The D-chiro-inositol paradox in the ovary. Fertility and Sterility, 95(8), 2515-2516. DOI: 10.1016/j.fertnstert.2011.05.027 

[9] Caprio, F., D’Eufemia, M.D., Trotta, C., Campitiello, M.R., Ianniello, R., Mele, D., & Colacurci, N. (2015). Myo-inositol therapy for poor-responders during IVF: a prospective controlled observational trial. Journal of Ovarian Research, 8. DOI: 10.1186/s13048-015-0167-x 

[10] U.S National Library of Medicine. (2018, July 26). Spontaneous reproductive outcomes after oral inositol supplementation in infertile polycystic ovarian syndrome women. https://clinicaltrials.gov/ct2/show/NCT03598374 

[11] Lagana, A.S., Rossetti, P., Buscema, M., La Vignera, S., Condorelli, R.A., Gullo, G., Granese, R., & Triolo, O. (2016). Metabolism and ovarian function in PCOS women: A therapeutic approach with inositols. International Journal of Endocrinology, 2016, 1-9. https://doi.org/10.1155/2016/6306410

[12] Reproductive Science Center. (2015, August 14). Myo-inositol for fertility treatment. https://rscbayarea.com/integrative-medicine-blog/myo-inositol-for-fertility-treatment

[13] Pundir, J., Psaroudakis, D., Savnur, P., Bhide, P., Sabatini, L., Teede, H., Coomarasamy, A., & Thangaratinam, S. (2017). Inositol treatment of anovulation in women with polycystic ovary syndrome: a meta-analysis of randomized trials. An International Journal of Obstetrics and Gynaecoloy, 299-308. DOI: 10.1111/1471-0528.14754

[14] Benelli, E., Del Ghianda, S., Di Cosmo, C., & Tonacchera, M. (2016). A combined therapy with myo-inositol and d-chiro-inositol improves endocrine parameters and insulin resistance in PCOS young overweight women. International Journal of Endocrinology, 2016. https://doi.org/10.1155/2016/3204083

[15] Gurevich, Rachel. (2019, September 21). Here’s why an FSH test is important for monitoring your fertility. https://www.verywellfamily.com/day-3-fsh-levels-test-1960172

[16] Bhide, P., Pundir, J., Gudi, A., Shah, A., Homburg, R., & Acharya, G. (2019). The effect of myo-inositol/di-chiro-inositol on markers of ovarian reserve in women with PCOS undergoing IVF/ICSI: A systematic review and meta-analysis. Obstetrics & Gynaecology, 98(10). https://doi.org/10.1111/aogs.13625

[17] U.S. National Library of Medicine. (2011, April 20). Role of myo-inositol and d-chiro-inositol on oocyte quality. https://clinicaltrials.gov/ct2/show/NCT01338844

[18] Colazingari, S., Treglia, M., Najjar, R., & Bevilacqua, A. (2013). The combined therapy myo-inositol plus d-chiro-inositol, rather than d-chiro-inositol, is able to improve IVF outcomes: results from a randomized controlled trial. Archives of Gynecology and Obstetrics, 288, 1405-1411. https://doi.org/10.1007/s00404-013-2855-3